BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31676644)

  • 1. Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis.
    Barton S; Wakefield V; O'Mahony C; Edwards S
    BMJ Open; 2019 Oct; 9(10):e027765. PubMed ID: 31676644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
    Thurgar E; Barton S; Karner C; Edwards SJ
    Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis.
    Werner RN; Westfechtel L; Dressler C; Nast A
    Sex Transm Infect; 2017 May; 93(3):155-161. PubMed ID: 27803240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryotherapy to treat anogenital warts in nonimmunocompromised adults: Systematic review and meta-analysis.
    Bertolotti A; Dupin N; Bouscarat F; Milpied B; Derancourt C
    J Am Acad Dermatol; 2017 Sep; 77(3):518-526. PubMed ID: 28651824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
    Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod for anogenital warts in non-immunocompromised adults.
    Grillo-Ardila CF; Angel-Müller E; Salazar-Díaz LC; Gaitán HG; Ruiz-Parra AI; Lethaby A
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010389. PubMed ID: 25362229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital warts treatment: Beyond imiquimod.
    Yuan J; Ni G; Wang T; Mounsey K; Cavezza S; Pan X; Liu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1815-1819. PubMed ID: 29505317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
    Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
    BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
    Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
    Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital warts.
    Buck HW
    Clin Evid; 2006 Jun; (15):2149-61. PubMed ID: 16973081
    [No Abstract]   [Full Text] [Related]  

  • 12. Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Bertolotti A; Ferdynus C; Milpied B; Dupin N; Huiart L; Derancourt C
    Dermatol Ther (Heidelb); 2020 Apr; 10(2):249-262. PubMed ID: 32030564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of anogenital warts at home.
    Pleavin M
    Nurs Times; 2001 Feb 8-14; 97(6):37-8. PubMed ID: 11954248
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyphenon E: a new treatment for external anogenital warts.
    Tatti S; Stockfleth E; Beutner KR; Tawfik H; Elsasser U; Weyrauch P; Mescheder A
    Br J Dermatol; 2010 Jan; 162(1):176-84. PubMed ID: 19709100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
    Gross G
    Hautarzt; 2001 Jan; 52(1):6-17. PubMed ID: 11220242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of commonly used treatment for genital warts.
    Maw R
    Int J STD AIDS; 2004 Jun; 15(6):357-64. PubMed ID: 15186577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of genital warts.
    Kodner CM; Nasraty S
    Am Fam Physician; 2004 Dec; 70(12):2335-42. PubMed ID: 15617297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of genital human papillomavirus infections. Part II: Methods of treatment.
    Ling MR
    Int J Dermatol; 1992 Nov; 31(11):769-76. PubMed ID: 1385343
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
    Yan J; Chen SL; Wang HN; Wu TX
    Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
    Werner RN; Westfechtel L; Dressler C; Nast A
    Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.